Managing Director
Current▪ Responsible for whole business objectives, including sales revenue, profit, pipeline and distribution channel establishment▪ Responsible for organization including restructuring, talent acquisition and people development▪ Responsible for resource allocation according to strategy and priority for a new start-up▪ Communicated and collaborated with manufacturers such as BectonDickinson Korea, Abbott, Roche Dx and Siemens as business partners for strategic alignment▪ Negotiated… Show more ▪ Responsible for whole business objectives, including sales revenue, profit, pipeline and distribution channel establishment▪ Responsible for organization including restructuring, talent acquisition and people development▪ Responsible for resource allocation according to strategy and priority for a new start-up▪ Communicated and collaborated with manufacturers such as BectonDickinson Korea, Abbott, Roche Dx and Siemens as business partners for strategic alignment▪ Negotiated and developed potential pipeline and distribution channel for both of current and future business▪ Managed the implementation and monitoring of the business plan with integrated marketing communication▪ Took responsibilities in customer relationships especially with Key Opinion Leaders in university hospitals and societiesAchievements▪ Restructured existing sales organization for effectiveness, and organized each function almost from scratch SCM, Finance and Service for newly started company (since 2017)▪ Acquired new contract with Siemens in 2019, and especially an exclusive one with Roche Dx in 2020 through negotiation and competitive presentation (beginning from July, 2020)▪ Managed whole contract process with Roche Dx, take-over existing business and negotiation with university hospitals and general hospitals in Seoul-Metropolitan area▪ Recorded 36% growth and 40% over-achievement in 2020 with successful business acquisition from right pipeline strategy, marketing strategy and execution whilst defending existing business volume under negative surroundings due to sharp MIP cut down in mid of 2019 and COVID-19 pandemic situation▪ Successful new product line launch for BD MAX® PCR dx, with 12 GH accounts installation within 12 months (2019, July ~ 2020, June) before global supply issue due to COVID-19▪ Succeeded in MIP adjustment from HIRA (Health Insurance Review and Assessment Service) in 2020 with excellent collaboration working with BectonDickinson marketing and RA team Show less